Previous slide arrow

Save the Date!

We are looking forward to World Mitochondrial Diseases Week 2025! 15 - 21 September 2025

LHON Awareness Day - 19 September 2025
Light up for Mito - 20 September 2025

More information coming soon.

Save the Date! We are looking forward to World Mitochondrial Diseases Week 2025! 15 - 21 September 2025 LHON Awareness Day - 19th September 2025 Light up for Mito - 20th September 2025 More information coming soon.

New Resources for Patient Organisations

Our new free guides are now available, including information on fundraising, starting a Patient Organisation, creating and managing websites and getting the best out of social media.

Khondrion Press Release

On 7 November, biopharmaceutical company Khondrion announced the publication of results from their integrated Phase 2b clinical development programme which targets the underlying pathways of primary mitochondrial disease.

r


Mitochondrial diseases (mito) are a highly complex set of rare genetic disorders. Mito can cause any symptom in any organ at any age. They rob the body’s cells of energy causing debilitating and often life-threatening organ dysfunction.

About
MITO

NEWS

Primary Mitochondrial Myopathies: Patient Journey

Navigating the journey to gain a diagnosis of Primary Mitochondrial Myopathy can be unnecessarily long, intensely stressful, and fraught with obstacles....

Countdown to Rare Disease Day 2025!

The countdown is on to Rare Disease Day 2025 which takes place on 28 February....

Collaboration with MITGEST

IMP is proud to support MITGEST. This international consortium brings together world-class academic experts in mitochondrial research....

SIMPATHIC project prepares to launch clinical trial

The SIMPATHIC project is preparing to launch a clinical trial using Sildenafil as a potential treatment for Leigh syndrome.  ...

IMP joins UK MitoCohort Oversight Committee

IMP are delighted to have been asked to join the UK MitoCohort Oversight Committee. The UK Mitocohort is a UK wide database that collects clinical information on patients living with mito, to help advance understanding of the disease....

Meet
a member

The POLG Foundation

The PolG Foundation is committed to accelerating research efforts to develop effective treatments and, ultimately, a cure for POLG mitochondrial disorders.


Become
a member

Are you thinking of becoming an IMP member?

Patient Stories

Ellie was a fighter from birth. Born in October 2017, a lack of oxygen at birth meant she needed to spend the first week of life in intensive care. This early battle in life would later be a blessing in disguise as it meant she required regular neurological reviews to review how her brain and movement developed. Ellie’s early months were mainly happy. She cried, babbled and smiled like any baby does and loved baths with her big sister, kicking her legs to music and chatting away with her mum and dad.

About
IMP

International Mito Patients is a network of national patient organisations involved in mito. The national patient organisations support and advocate for patients, fund research, increase awareness and improve education in their country.

By joining forces, IMP represents a large group of patients, creating a stronger voice on an international level.

IMP’s mission is to increase the quality of life for people with mitochondrial disease by facilitating cross-border cooperation and collaboration among national patient organisations.


Stay up
to date

Translate
Scroll to Top
Skip to content